Ryeqo

News

Around 1,000 women in England a year with endometriosis will soon have access to the first daily oral therapy, Gedeon Richter's Ryeqo, via the NHS.

News

Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.